pLenti6/V5 Directional TOPO Cloning Kit from Invitrogen
Mouse Anti-Cow LTBP-2 Monoclonal Antibody, Unconjugated, Clone 7B10 from Santa Cruz Biotechnology, Inc.
...ogen Synthetic peptide: ASGPMPAPPRQERKRTQDALI co...3 of Rat Kv4.2. Reactivity / Specificity Cross-r...(100% identity with immunogen), Mouse (100% identi...unogen) and Ferret (100% identity with immunogen) ...
Mouse Anti-Gemin 2 Monoclonal Antibody, Unconjugated, Clone 2E17 from ImmuQuest Ltd.
Biology Products:(Date:11/23/2009)..., DURHAM, N.H. University of New Hampshire micr...ling $498,115 to advance understanding of the acti...ntial to enrich nutrient-poor and contaminated soi...re (USDA) awarded Tisa, a professor of molecular, ...ore the symbiotic relationship between the bacteri...
(Date:11/23/2009)... , University of Southern California biomedical e...to develop a new tool to help clinicians distingui... from chronic problems manageable with drugs and l...theters inserted into the arteries feeding the hea..."lumen") of these blood vessels, often revealing d...
(Date:11/23/2009)... Amphibians like frogs and toads have existed for... didn,t, but a new aquatic fungus is threatening t...le in the November issue of Microbiology Today . ...(Bd), was found to be associated with waves of amp...stern Australia in the 1990,s. Bd infects over 350...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 1Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 2NFL National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 59511 1NFL National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 59511 2NFL National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 59511 3NFL National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 59511 4NFL National Dairy Council Take Aim at Childhood Obesity With Fuel Up to Play 60 59511 5LTC Hotline Offers Competitive Long Term Care Insurance Quotes by Phone and Internet 59506 1LTC Hotline Offers Competitive Long Term Care Insurance Quotes by Phone and Internet 59506 2(Date:11/19/2009)...EAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics In... in a randomized Phase 2B study of AEG35156, a tar...nt for multiple oncology indications. ,, The st...udy of the X-Linked Inhibitor of Apoptosis (XIAP) ...dose Cytarabine and Idarubicin in AML Following Fa...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies For...o Coordinate Best Practices in Risk Reduction ,F...wide Gene Synthesis Capacity , ...ld’s leading gene synthesis companies today ...screening protocol to promote biosecurity in the g...
(Date:11/19/2009)... VIENNA, Austria, November 19 AF...m on one product candidate at an unexpectedly earl... is planned to enter into,Phase II clinical trial ...ately follows the completion of two Phase I trials...sed its fast decision on the first interim,analysi...
(Date:11/18/2009)...he National Institute of Standards and Technology ...ensive method for detecting and measuring elusive ...nvisible spoilage in food or pesticides distribute...s more sensitive than conventional techniques for ...arlike water molecules, having distinct electrical...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2